(Total Views: 481)
Posted On: 09/18/2020 9:09:29 AM
Post# of 154089
Question re: interim analysis-
Is this just the DSMC looking at the data and stopping due to ethical concerns with the criteria being a statistically significant difference in the number of deaths in placebo vs. LL (i.e. DSMC performs the analysis, not CYDY)?
i.e. All the p-value calc's everyone has posted here is what the DSMC would be calculating, not CYDY?
CYDY doesn't actually get all of the interim data unblinded and perform a full analysis similar to what they'd do at the end of the trial, do they?
Is this just the DSMC looking at the data and stopping due to ethical concerns with the criteria being a statistically significant difference in the number of deaths in placebo vs. LL (i.e. DSMC performs the analysis, not CYDY)?
i.e. All the p-value calc's everyone has posted here is what the DSMC would be calculating, not CYDY?
CYDY doesn't actually get all of the interim data unblinded and perform a full analysis similar to what they'd do at the end of the trial, do they?
(1)
(0)
